Simplified method using left atrial volume and natriuretic peptides streamlines diagnosis of heart failure with preserved ...

The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for TransCon ® CNP (navepegritide) for the treatment of children with achondroplasia, a rare ...